The Journey since 2002
Developing novel solutions in healthcare through international collaboration.
Unique biomaterials, food supplements, tissue engineering platforms, developed in Japan, but not much known to the outside world, we have been able to identify, spearhead international inter-disciplinary research programs and unravel their hidden potentials and develop path-breaking solutions in healthcare. This has been made possible through coordinated team effort overcoming several bottle necks in a journey of more than two decades.
Company History
| Aug 2002 | Company established; began exporting medical devices |
| Feb 2004 | Started research on corneal limbal stem cells with Sankara Nethralaya, Chennai, India |
| Sep 2005 | Established Nichi-in Centre for Regenerative Medicine (NCRM) in Chennai, India |
| Oct 2006 | Held the 1st NCRM NICHE conference, an academic meeting in the field of regenerative medicine |
| Mar 2008 | Provided AIET cancer immunotherapy technology to Malaysia |
| Oct 2011 | Announced clinical research results on corneal endothelial cells (ICE-TUBE) |
| Nov 2013 | Established Medinippon Healthcare Co., Ltd. in India |
| Jan 2014 | Began medical device export consulting |
| Apr 2015 | Tech-transfer collaboration with Vinmec Hospital, Hanoi, Vietnam for AIET Immune cell therapy for cancer. |
| Jan 2016 | Took over publication of Journal of Stem Cells and Regenerative Medicine for GSZ, Germany. |
| Oct 2017 | Held the 12th NCRM NICHE Conference in Tokyo |
| Dec 2017 | Began consulting on regenerative medicine technology development |
| Jun 2018 | Began clinical research on health food “nichi Glucan®” with Chikamori Hospital (Kochi Prefecture) |
| Apr 2020 | Granted patent on BEES-HAUS cell therapy for male urethral stricture |
| Aug 2022 | Published paper on neu REFIX® clinical trial results for muscular dystrophy |
| Sep 2023 | Established NCRM Joint Research Institute in Mauritius |
| Aug 2024 | Obtained ODD and RPD designations from the US FDA for health food “neu REFIX®” |
| Aug 2024 | Presented clinical trial results for health food “nichi BRITE®” at the American Society of Clinical Oncology (ASCO) conference |
| Apr 2025 | The First clinical application of BEES-HAUS cell therapy was started in Japan following a successful tech-transfer and approval as per Act on safety of regenerative medicine of Japan. |
| Jan 2026 | Obtained approval for Festigel in Mauritius. |
| May 2026 | Encouraging results of the BHES-HAUS: simplified cell therapy for male urethral stricture, accepted for presentation in Americal Urological Association meeting, 2026 in Washington DC, USA. |
Affiliated Institutions: NCRM Japan-India Regenerative Medicine Center (India)
Soul Synergy NCRM Joint Research Institute (Mauritius)
Affiliated Companies: Medinippon Healthcare Co., Ltd. (India)
Global Niche Corp., (USA)
Latest News
XIX Fujio Cup Quiz Champions with their Chancellor and Professor
*The images shown are for illustrative purposes only and may differ from actual research or medical settings.